6 min read
Trials
Trial Tuesday: The Race Is On
Two oncology and immunology races tighten, and two smaller biotechs turn mid-stage data into late-stage leverage.
Two oncology and immunology races tighten, and two smaller biotechs turn mid-stage data into late-stage leverage.